Reversal of pre-existing NGFR-driven tumor and immune therapy resistance

por Julia Boshuizen, David W. Vredevoogd, Oscar Krijgsman, Maarten A. Ligtenberg, Stephanie Blankenstein, Beaunelle de Bruijn, Dennie T. Frederick, Juliana C. N. Kenski, Mara Parren, Marieke Brüggemann, Max F. Madu, Elisa A. Rozeman, Ji-Ying Song, Hugo M. Horlings, Christian U. Blank, Alexander C. J. van Akkooi, Keith T. Flaherty, Genevieve M. Boland, Daniel S. Peeper
Publicado 2020

Effect of a multidisciplinary Severe Immunotherapy Complications Service on outcomes for patients receiving immune checkpoint inhibitor therapy for cancer

por Michael Dougan, Justine Cohen, Dejan Juric, Leyre Zubiri, Ryan J Sullivan, Daniel A Zlotoff, Yevgeniy R Semenov, Sara R Schoenfeld, Genevieve M Boland, Amanda C Guidon, Laura Petrillo, Alexandra-Chloe Villani, Gabriel E Molina, Sienna M Durbin, Molly F Thomas, Alex T Faje, Michelle Rengarajan, Daniel Okin, Benjamin D Medoff, Mazen Nasrallah, Minna J Kohler, Jocelyn R Farmer, Aditya Bardia, Steven M Blum, Rebecca K Leaf
Publicado 2021

Resistance to checkpoint blockade therapy through inactivation of antigen presentation

por Moshe Sade-Feldman, Yunxin J. Jiao, Jonathan H. Chen, Michael S. Rooney, Michal Barzily-Rokni, Jean-Pierre Eliane, Stacey L. Bjorgaard, Marc R. Hammond, Hans Vitzthum, Shauna M. Blackmon, Dennie T. Frederick, Mehlika Hazar-Rethinam, Brandon A. Nadres, Emily E. Van Seventer, Sachet A. Shukla, Keren Yizhak, John P. Ray, Daniel Rosebrock, Dimitri Livitz, Viktor Adalsteinsson, Gad Getz, Lyn M. Duncan, Bo Li, Ryan B. Corcoran, Donald P. Lawrence, Anat Stemmer-Rachamimov, Genevieve M. Boland, Dan A. Landau, Keith T. Flaherty, Ryan J. Sullivan, Nir Hacohen
Publicado 2017